TeVido BioDevices

TeVido’s skin cell grafts restore lost skin color in vitiligo / white scars & accelerate wound healing; ~$4B serviceable market, $3.5M &3 yrs to reach profits!

  • Stage Product In Market
  • Industry Biotechnology
  • Location Austin, TX, USA
  • Currency USD
  • Founded January 2016
  • Employees 5
  • Incorporation Type C-corp
  • Website tevidobiodevice.com

Company Summary

TeVido BioDevices makes life changing skin cell transplants (SCT) readily available. Our platform, TruPigment, is on the market and has user traction. TruPigment™ restores lost skin color and repairs wounds, including burns. Serviceable market (U.S.) is ~ $4B across numerous indications. TeVido is capital efficient, anticipating profitability in 24-30 months. This opportunity is de-risked and primed for growth.

Team

  • Laura Bosworth-Bucher
    CEO

    Fortune 50 exec with 23+ yrs of broad ranging business and mgmt experience. With 15 years of product , service and process development at both engineering & marketing levels. She has a strong track-record in managing new products, supporting sales & has launched new business concepts. Her 7+ years in corporate strategy includes building strategic partnerships. As an engineer, she has a background in manufacturing..

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free